Advertisement

Hypertrophic obstructive cardiomyopathy and mitral regurgitation in Libman–Sacks endocarditis

  • Go Yamashita
  • Naoki Kanemitsu
  • Yasuaki Nakashima
  • Takehiko Matsuo
  • Takeichiro Nakane
  • Masanori Honda
  • Hitoshi Okabayashi
Case Report
  • 11 Downloads

Abstract

Hypertrophic obstructive cardiomyopathy in Libman–Sacks endocarditis is quite rare and the correct etiological relationship between them is unknown. Some changes may cause a secondary disorganization of the ordinary muscle structure, making a disarray pattern with irregular interwoven myocyte fibers. This case report describes one of the first cases of ventricular septal myectomy and mitral valve replacement for hypertrophic obstructive cardiomyopathy and mitral valve regurgitation associated with Libman–Sacks endocarditis.

Keywords

Libman–Sacks Endocarditis Hypertrophic obstructive cardiomyopathy Mitral regurgitation 

Notes

Acknowledgements

The authors have nothing to disclose with regard to commercial support.

References

  1. 1.
    Libman E, Sacks B. A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med. 1924;33:701–37.CrossRefGoogle Scholar
  2. 2.
    Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113:1807–16.CrossRefGoogle Scholar
  3. 3.
    Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008;29:270–6.CrossRefGoogle Scholar
  4. 4.
    Arbustini E, Narula N, Tavazzi L, et al. The MOGE(S) classification of cardiomyopathy for clinicians. J Am Coll Cardiol. 2014;64:304–18.CrossRefGoogle Scholar
  5. 5.
    Anastasiadis GP, Moyssakis I, Boki K, Kyriakidis M. Hypertrophic cardiomyopathy in systemic lupus erythematosus. Mayo Clin Proc. 2001;71:111.CrossRefGoogle Scholar
  6. 6.
    Doherty NE, Siegel RJ. Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J. 1985;110:1257–65.CrossRefGoogle Scholar
  7. 7.
    Asherson RA, Ames D, Coltart J, Byrne C, Hughes GR. Hypertrophic cardiomyopathy in systemic lupus erythematosus and “lupus-like” disease. Chance association? A report of 2 cases. J Rheumatol. 1992;19:1973–7.Google Scholar
  8. 8.
    Kotani T, Takeuchi T, Sakamoto M, et al. A case of systemic lupus erythematosus associated with hypertrophic cardiomyopathy. Nihon Rinsho Meneki Gakkai Kaishi. 2005;28(6):413–7.CrossRefGoogle Scholar
  9. 9.
    Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med. 1996;335:1424.CrossRefGoogle Scholar
  10. 10.
    Kotkar KD, Said SM. Libman–Sacks endocarditis in a patient with antiphospholipid syndrome. Ann Thorac Surg. 2016;102:e31–2.CrossRefGoogle Scholar

Copyright information

© The Japanese Association for Thoracic Surgery 2018

Authors and Affiliations

  1. 1.Department of Cardiovascular SurgeryMitsubishi Kyoto HospitalKyotoJapan
  2. 2.Department of PathologyMitsubishi Kyoto HospitalKyotoJapan

Personalised recommendations